Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Healthtrust
Citi
Daiichi Sankyo
Farmers Insurance
Moodys

Generated: March 26, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Mirodenafil

« Back to Dashboard

US Patents for Mirodenafil

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Mirodenafil ➤ Try a Free Trial Method of treating pulmonary arterial hypertension Cipla Limited (Mumbia, IN) ➤ Try a Free Trial
Mirodenafil ➤ Try a Free Trial Organic compounds INTRA-CELLULAR THERAPIES, INC. (New York, NY) ➤ Try a Free Trial
Mirodenafil ➤ Try a Free Trial Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) Adverio Pharma GMBH (Schonefeld, DE) ➤ Try a Free Trial
Mirodenafil ➤ Try a Free Trial Use of phosphodiesterase inhibitors for treating multidrug resistance St. John's University (Jamaica, NY) ➤ Try a Free Trial
Mirodenafil ➤ Try a Free Trial Composition for reducing skin wrinkles including PDE5 inhibitor SK CHEMICALS CO., LTD. (Seongnam, Gyeonggi-Do, KR) ➤ Try a Free Trial
Mirodenafil ➤ Try a Free Trial Treatment of erectile dysfunction and other indications Strategic Science & Technologies, LLC (Cambridge, MA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Mirodenafil

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Mirodenafil European Patent Office 3177627 2034-08-07 ➤ Try a Free Trial
Mirodenafil Japan 2017523219 2034-08-07 ➤ Try a Free Trial
Mirodenafil Taiwan 201613932 2034-08-07 ➤ Try a Free Trial
Mirodenafil World Intellectual Property Organization (WIPO) 2016022893 2034-08-07 ➤ Try a Free Trial
Mirodenafil Argentina 081628 2030-05-26 ➤ Try a Free Trial
Mirodenafil Australia 2011257335 2030-05-26 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Daiichi Sankyo
Healthtrust
Argus Health
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: